Business

9 articles

The companies, investors, and industry shaping the future of longevity—from biotech startups to major funding rounds and market trends.

news

Function Secures $450M Growth Financing From General Catalyst

The preventive-health platform says the backing from General Catalyst’s Customer Value Fund will help it bring lab testing, medical imaging, and personalized health data to millions more people.

Editorial Team · Jul 31, 2026 · 3 min read

news

Eli Lilly to Acquire AtaiBeckley for up to $3.8B, Betting Big on Psychedelic Medicine

The pharma giant is buying the clinical-stage biotech behind BPL-003 — a synthetic 5-MeO-DMT for treatment-resistant depression — in a deal that pushes psychedelic therapy firmly into the mainstream drug industry.

Editorial Team · Jul 17, 2026 · 1 min read

news

Czech Medtech HTG Medical Wins EU Certification and Passes €1M to Automate ICU Care

The HTG Urogram automates one of the ICU's most mundane hourly tasks — measuring a patient's urine output — and feeds it straight into hospital systems. Now CE-marked and past €1M in funding, the startup is heading for global markets.

Anton Dalsätt · Jul 16, 2026 · 4 min read

news

Neko Health Raises $700M Series C Ahead of US Launch

The preventive-scanning company co-founded by Spotify's Daniel Ek has raised one of European health tech's largest-ever rounds — backed by Lightspeed and a long list of high-profile names including Mark Zuckerberg — as it prepares to open in New York.

Editorial Team · Jul 15, 2026 · 4 min read

news

Beckham-Backed Supplement Brand IM8 Secures $1 Billion Financing from General Catalyst

Prenetics has landed up to $1 billion to fuel its supplement brand IM8 — but the structure is the story: no equity, no dilution. General Catalyst funds the marketing and takes a capped slice of the revenue it generates.

Editorial Team · Jul 15, 2026 · 4 min read

Two hands holding a jar of green Reformed matcha against a blue background

news

Functional-Drinks Brand Reformed Raises $22M Series A to Enter the US

The UK startup turns instant coffee and matcha into functional-wellness products — with collagen, creatine, and mushrooms mixed in. Two years in, it says it's already at ~$70M in annual revenue.

Editorial Team · Jul 10, 2026 · 3 min read

Hand holding a small transparent microneedle patch against a blue background

news

Anodyne Nanotech Raises $12.6M Series A to Take a Once-Weekly GLP-1 Patch into Human Trials

The Boston biotech wants to replace the GLP-1 injection with a room-temperature patch — no needles, no cold storage. Its Series A funds the first clinical test of that idea.

Editorial Team · Jun 30, 2026 · 3 min read

Four members of the Peers Capital team standing together against a light wall

news

A new syndicate, Peers Capital, launches to fund preventive health at the earliest stage

The investor group is backing pre-seed and seed founders across diagnostics, recovery, and longevity through a deal-by-deal model — and they have already closed its first investments

William Ferreira Andrén · Jun 26, 2026 · 4 min read

Researcher in a white lab coat working beside robotic laboratory equipment

news

Insilico Medicine Signs AI Drug-Discovery Deal With SK Biopharmaceuticals Worth Up to $2.5 Billion

The AI-driven biotech will run target-to-candidate discovery for neuroimmune disorders, while its Korean partner takes the molecules through late-stage development - Insilico's largest potential deal in Asia-Pacific to date.

Editorial Team · Jun 24, 2026 · 4 min read